Corpay has underperformed the Technology sector over the past year, but analysts are cautiously optimistic about the stock’s ...
Spyre Therapeutics (SYRE) has strong technical momentum and is trading at a new 52 week high. SYRE maintains a 100% “Buy” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback